Are Myeloproliferative neoplasms a risk factor for Heparin-Induced Thrombocytopenia?

Br J Haematol. 2016 Nov;175(3):537-539. doi: 10.1111/bjh.13874. Epub 2015 Dec 23.

Authors

Julien Bovet¹, Emmanuel De Maistre², Yannick Bejot³, François Girodon²

Affiliations

¹ Haematological Laboratory, Dijon Hospital, Dijon, France. [email protected].
² Haematological Laboratory, Dijon Hospital, Dijon, France.
³ Neurology Department, Dijon Hospital, Dijon, France.

PMID: 26699699
DOI: 10.1111/bjh.13874

No abstract available

Keywords: essential thrombocythaemia; heparin-induced thrombocytopenia; thrombocytopenia.

MeSH terms

Adult
Aged
Female
Heparin / adverse effects*
Humans
Male
Middle Aged
Myeloproliferative Disorders / complications*
Myeloproliferative Disorders / pathology
Risk Factors
Thrombocytopenia / chemically induced*

Substances

Heparin